Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02237079 · ClinicalTrials.gov registry record · Phase 4
Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)
A Phase 4 study, sponsored by Tulane University Health Sciences Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT02237079 is a Phase 4 study that has completed, run by Tulane University Health Sciences Center. The registered enrollment target is 17 participants.
The verdict
NCT02237079, a Phase 4 study, has completed, sponsored by Tulane University Health Sciences Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
The goal of this pilot clinical study is to perform a randomized placebo-controlled study to assess the beneficial effect of a 3 month-treatment with Bazedoxifene/Conjugated Estrogens (BZA/CE) vs. placebo on glucose homeostasis and body composition in 20 post-menopausal women. The recruitment will be performed at Tulane Health Sciences Center.
Interventions
- DRUG Placebo Oral Tablet
- DRUG Bazedoxifene/Conjugated Estrogens (BZA/CE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-12 |
| Est. Completion | 2018-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02237079
The ClinicalTrials.gov registry entry for NCT02237079 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University Health Sciences Center, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Oral Tablet is the first listed.
NCT02237079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02237079 about?
NCT02237079 is a clinical study titled "Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)". The goal of this pilot clinical study is to perform a randomized placebo-controlled study to assess the beneficial effect of a 3 month-treatment with Bazedoxifene/Conjugated Estrogens (BZA/CE) vs. placebo on glucose homeostasis and body composition in 20 post-menopausal women. The recruitment will b...
What is the current status of trial NCT02237079?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2014-12. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02237079?
The interventions under investigation include: Placebo Oral Tablet (DRUG), Bazedoxifene/Conjugated Estrogens (BZA/CE) (DRUG).
Who is sponsoring clinical trial NCT02237079?
This trial is sponsored by Tulane University Health Sciences Center, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.